TYRO3 - TYRO3 Receptor Tyrosine Kinase

TYRO3 (TYRO3 Receptor Tyrosine Kinase)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TYRO3 - TYRO3 Receptor Tyrosine Kinase</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>TYRO3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>TYRO3 - TYRO3 Receptor Tyrosine Kinase</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=TYRO3" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Introduction

TYRO3 (TYRO3 Receptor Tyrosine Kinase)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TYRO3 - TYRO3 Receptor Tyrosine Kinase</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>TYRO3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>TYRO3 - TYRO3 Receptor Tyrosine Kinase</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=TYRO3" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Introduction

TYRO3 is the founding member of the TAM receptor tyrosine kinase family, which also includes AXL and MERTK. Originally identified as a proto-oncogene in chickens, TYRO3 has emerged as a critical regulator of neural development, synaptic function, and neuronal survival in the mammalian central nervous system (CNS)[@graham2014]. The gene encodes a transmembrane receptor tyrosine kinase that is primarily expressed in neurons, oligodendrocytes, and to a lesser extent in microglia, where it mediates cell survival, migration, and immune regulation through activation of downstream signaling cascades.

The significance of TYRO3 in neurodegeneration has become increasingly apparent as research reveals its multifaceted roles in protecting neurons from toxic insults, regulating synaptic plasticity, and maintaining myelin integrity. Unlike MERTK, which is predominantly expressed in cells of myeloid origin, TYRO3 is highly expressed in neuronal populations, suggesting distinct but complementary functions within the TAM receptor family["@lew2014"]. In Alzheimer's disease (AD), TYRO3 expression is often downregulated, correlating with disease severity, while in Parkinson's disease (PD), TYRO3 signaling provides trophic support to dopaminergic neurons.

This comprehensive examination explores TYRO3's structure, signaling mechanisms, expression patterns, disease associations, and therapeutic potential in neurodegenerative disorders. Understanding the unique roles of TYRO3 within the TAM family provides insights into disease mechanisms and identifies potential therapeutic targets for intervention in progressive neurological conditions.

Gene Structure and Protein Architecture

Genomic Organization

The TYRO3 gene (NCBI Gene ID: 7304, Ensembl ID: ENSG00000092470) is located on chromosome 15q15.2, spanning approximately 35 kilobases of genomic DNA. The gene consists of 22 exons encoding a full-length receptor tyrosine kinase of 1,903 amino acids[@graham2014]. The chromosomal region 15q15.2 has been implicated in various neurological conditions, and copy number variations encompassing TYRO3 have been reported in neurodevelopmental disorders.

The TYRO3 promoter region contains several transcription factor binding sites including SP1, AP-2, and NF-κB response elements, enabling regulation by growth factors and inflammatory cytokines. Polymorphisms in the TYRO3 promoter and coding regions have been associated with altered gene expression and modified risk of Alzheimer's disease[@smith2022].

Protein Domain Structure

The TYRO3 protein (UniProt ID: Q06418, OMIM: 600341) possesses a complex domain architecture enabling its diverse functions:

Extracellular Domain (1-495 amino acids): The N-terminal extracellular region contains two immunoglobulin-like (Ig-like) domains (D1 and D2) and two fibronectin type III (FNIII) domains. The Ig-like domains mediate ligand binding, particularly recognition of Gas6 and Protein S with high affinity[@binder2011]. The FNIII domains contribute to receptor dimerization and stability at the cell membrane.

Transmembrane Domain (496-520 amino acids): A single-pass transmembrane helix anchors the receptor in the lipid bilayer, facilitating proper localization and enabling signal transduction across the membrane.

Cytoplasmic Kinase Domain (521-903 amino acids): The intracellular portion contains the catalytic tyrosine kinase domain responsible for autophosphorylation and downstream signaling. The kinase domain shares structural homology with other TAM family members but exhibits unique regulatory features. Key tyrosine residues (Y681, Y685, Y686, Y801, Y806) serve as phosphorylation sites mediating interaction with adaptor proteins including GRB2, PLCγ, and phosphatidylinositol 3-kinase (PI3K)[@tinker2016].

Isoforms and Alternative Splicing

Multiple TYRO3 isoforms have been identified through alternative splicing:

• Full-length TYRO3 (fl-TYRO3): The canonical transmembrane receptor (1,903 amino acids) expressed predominantly in neurons
• Soluble TYRO3 (s-TYRO3): Generated through proteolytic cleavage, containing the extracellular domain without the transmembrane and kinase regions. Soluble TYRO3 can function as a decoy receptor, antagonizing ligand binding to membrane-bound receptor
• TYRO3-ΔK: A variant isoform with truncation in the kinase domain, potentially functioning as a dominant-negative regulator

TAM Receptor Family Overview

Family Members and Evolution

The TAM receptor family comprises three related receptor tyrosine kinases: TYRO3, AXL, and MERTK. These receptors share common structural features and ligand recognition patterns, having evolved from a common ancestor with distinct but overlapping functions[@graham2014]. TYRO3 is the most ancient member, present in invertebrates, while AXL and MERTK evolved later in vertebrates.

TYRO3 was the first TAM receptor identified, originally as a proto-oncogene in chickens (c-eyk). It is expressed primarily in the nervous system, particularly in neurons and oligodendrocytes, where it regulates synaptic function, myelination, and neuronal survival[@patel2010].

AXL (from "anexelekto," Greek for "uncontrolled") was discovered as a transforming gene in chronic myeloid leukemia. It is widely expressed in immune cells, endothelial cells, and various tissues.

MERTK (from "rat sarcoma virus oncogene homolog") is predominantly expressed in cells of the myeloid lineage, especially macrophages and microglia.

Shared Ligand System: Gas6 and Protein S

Both Gas6 (Growth Arrest Specific 6) and Protein S serve as shared ligands for all three TAM receptors:

• Gas6: Binds all three TAM receptors with highest affinity for TYRO3, intermediate for AXL, and lowest for MERTK[@graham2014]. Gas6 contains an N-terminal gamma-carboxyglutamic acid (Gla) domain that enables calcium-dependent binding to phosphatidylserine.
• Protein S: Primarily a cofactor for activated protein C in coagulation, Protein S also functions as a TAM ligand with binding preference for TYRO3 and MERTK.

Signaling Pathways and Molecular Mechanisms

Activation Mechanisms

TYRO3 activation occurs through multiple mechanisms:

Ligand-Dependent Activation: Binding of Gas6 or Protein S to the extracellular domain induces receptor dimerization and autophosphorylation on key tyrosine residues. The Gla domain of these ligands bridges apoptotic cells bearing phosphatidylserine to TYRO3, though this mechanism is more prominent for MERTK[@zhou2019].

Ligand-Independent Activation: TYRO3 can also be activated through:

• Heterodimerization with other TAM receptors
• Interaction with cell surface proteins
• Mechanical stress

Downstream Signaling Cascades

Activated TYRO3 triggers multiple downstream signaling pathways:

PI3K/AKT Pathway: TYRO3 activates PI3K leading to AKT phosphorylation. The PI3K/AKT pathway promotes:

• Neuronal survival through phosphorylation of BAD and caspase-9
• Metabolic regulation through mTOR activation
• Protein synthesis and cellular growth
• Synaptic plasticity[@tinker2016]

• Neuronal differentiation and development
• Transcriptional activation of immediate-early genes
• Synaptic formation and remodeling

• Expression of anti-apoptotic genes
• Regulation of neural stem cell proliferation
• Modulation of immune responses[@liu2021]

• Inositol trisphosphate (IP3) production
• Calcium release from intracellular stores
• Synaptic transmission modulation

Neuronal Signaling Specificity

TYRO3 signaling in neurons exhibits unique features:

Synaptic Function: TYRO3 localizes to synapses where it regulates:

• Synaptic vesicle trafficking
• Postsynaptic density organization
• Excitatory neurotransmission[@ko2020]

• Growth cone steering
• Fasciculation of axons
• Myelination initiation[@chen2022]

Expression Patterns

Central Nervous System Expression

Within the CNS, TYRO3 is predominantly expressed in neurons and oligodendrocytes[@patel2010]:

Neuronal Expression: TYRO3 is highly expressed in neurons throughout the brain, with highest levels in:

• Hippocampus (CA1-CA3 regions)
• Cerebral cortex (layers II-VI)
• Cerebellum (Purkinje cells)
• Substantia nigra (dopaminergic neurons)

Oligodendrocyte Expression: TYRO3 is expressed in oligodendrocyte precursor cells (OPCs) and mature oligodendrocytes:

• Regulates OPC proliferation and differentiation
• Controls myelination during development and repair
• Maintains myelin integrity in adults[@chen2022]

Peripheral Expression

TYRO3 is expressed in various peripheral tissues:

• Retina: High expression in retinal pigment epithelium (RPE) cells[@binder2011]
• Testis: Expression in Sertoli cells
• Lung: Low-level expression in epithelial cells
• Endothelial Cells: Expression in vascular endothelial cells[@kim2021]

Disease Associations

Alzheimer's Disease

TYRO3 plays critical roles in Alzheimer's disease pathogenesis:

Neuronal Survival: TYRO3-mediated signaling protects neurons from amyloid-beta toxicity[@liu2018]. Loss of TYRO3 function renders neurons more vulnerable to:

• Oxidative stress
• [Excitotoxicity](/mechanisms/excitotoxicity)
• Apoptotic cell death

• Impaired LTP (long-term potentiation)
• Synaptic loss
• Memory deficits

• Phagocytic activity
• Inflammatory responses
• Neuroinflammation severity[@zhang2020]

• [Hippocampus](/brain-regions/hippocampus)
• Cerebral cortex
• Areas surrounding amyloid plaques

Parkinson's Disease

In Parkinson's disease, TYRO3 is implicated in:

Dopaminergic Neuron Survival: TYRO3 signaling provides trophic support to dopaminergic neurons in the substantia nigra[@xu2019]. Loss of TYRO3 function may contribute to:

• Increased susceptibility to oxidative stress
• Impaired mitochondrial function
• Neuronal death

Therapeutic Potential: TYRO3 agonists could protect dopaminergic neurons in PD[@lee2023].

Multiple Sclerosis and Demyelination

TYRO3 is essential for myelination and remyelination:

Myelination: During development, TYRO3 regulates:

• Oligodendrocyte precursor cell differentiation
• Myelin sheath formation
• Myelin thickness and integrity[@chen2022]

• TYRO3 expression increases in OPCs surrounding lesions
• TYRO3 signaling promotes remyelination
• TYRO3 deficiency impairs repair[@park2020]

Retinal Degeneration

TYRO3 mutations cause autosomal recessive retinal degeneration:

Retinal Pigment Epithelium: TYRO3 is essential for RPE function:

• Phagocytosis of photoreceptor outer segments
• Retinal homeostasis
• Photoreceptor survival[@yang2018]

• Progressive vision loss
• Photoreceptor degeneration
• Complete blindness in advanced cases

Therapeutic Implications

TYRO3 Agonists

Activating TYRO3 signaling provides therapeutic benefits:

Mechanism: Agonists would enhance:

• Neuronal survival signaling
• Synaptic plasticity
• Myelination and remyelination
• Antioxidant defenses

• Recombinant Gas6 administration
• Small molecule TYRO3 activators
• Gene therapy approaches

Combination Therapy

TYRO3 activation combined with other approaches may provide synergistic benefits[@tang2022]:

• With amyloid-targeting therapies: Enhanced neuronal protection
• With growth factors: Synergistic neuroprotection
• With anti-inflammatory agents: Reduced neuroinflammation

Biomarker Potential

TYRO3 and its ligands may serve as biomarkers:

• Soluble TYRO3: CSF levels may reflect neuronal injury
• Gas6: CSF Gas6 levels correlate with disease severity

Research Directions

Unresolved Questions

Several key questions remain:

Emerging Areas

Single-Cell Analysis: Single-cell RNA sequencing is revealing cell type-specific TYRO3 expression patterns.

Structural Biology: Crystal structures of TYRO3 domains are enabling rational drug design.

Animal Models: New genetic models allow dissection of TYRO3 function in specific cell types and disease contexts.

Molecular Mechanisms of Neuroprotection

Anti-Apoptotic Signaling

TYRO3-mediated neuroprotection operates through multiple anti-apoptotic mechanisms:

BAD Phosphorylation: Activated TYRO3 signals through PI3K/AKT to phosphorylate BAD, preventing it from inhibiting anti-apoptotic BCL-2 proteins. This promotes neuronal survival under conditions of apoptotic stress[@tinker2016].

Caspase Inhibition: TYRO3 signaling can inhibit caspase-9 and caspase-3 activation, blocking the apoptotic cascade at key points. This mechanism is particularly important in amyloid-beta toxicity scenarios.

Mitochondrial Protection: TYRO3 helps maintain mitochondrial integrity by:

• Promoting BCL-2 expression
• Inhibiting mitochondrial permeability transition
• Supporting ATP production under stress

Oxidative Stress Response

TYRO3 protects neurons from oxidative stress through:

Antioxidant Gene Expression: TYRO3/STAT3 signaling promotes expression of antioxidant enzymes including superoxide dismutase (SOD) and catalase.

NADPH Oxidase Regulation: TYRO3 inhibits NADPH oxidase activity in microglia, reducing production of reactive oxygen species (ROS) that can damage neurons.

Glutathione Regulation: TYRO3 signaling influences glutathione metabolism, enhancing cellular capacity to neutralize ROS.

Excitotoxicity Protection

TYRO3 provides protection against glutamate excitotoxicity:

Glutamate Receptor Regulation: TYRO3 signaling modulates NMDA and AMPA receptor function, reducing calcium influx that triggers excitotoxic cell death.

Calcium Homeostasis: TYRO3 activates calcium-regulating pathways that maintain proper cytosolic calcium concentrations.

Metabolic Support: TYRO3 promotes glycolytic metabolism that provides energy for ion pumps maintaining membrane potential.

Developmental Roles

Neuronal Development

During CNS development, TYRO3 plays essential roles:

Neurogenesis: TYRO3 signaling in neural stem cells promotes proliferation and differentiation into neuronal lineages[@liu2021]. Loss of TYRO3 leads to reduced neurogenesis in the subventricular zone and hippocampus.

Migration: TYRO3 guides neuronal migration during cortical development through interactions with the extracellular matrix.

Axon Pathfinding: TYRO3 on growth cones responds to guidance cues, directing axons to their correct targets.

Synaptogenesis

TYRO3 is crucial for synapse formation:

Presynaptic Assembly: TYRO3 localizes to presynaptic terminals where it regulates vesicle trafficking and neurotransmitter release[@ko2020].

Postsynaptic Specialization: Postsynaptic TYRO3 clusters at dendritic spines, organizing postsynaptic density proteins.

Synaptic Maintenance: TYRO3 signaling maintains synaptic structure throughout life. TYRO3 deficiency leads to progressive synapse loss.

Myelination

TYRO3 orchestrates oligodendrocyte development[@chen2022]:

OPC Proliferation: TYRO3 promotes proliferation of oligodendrocyte precursor cells in response to growth factors.

Differentiation: TYRO3 signaling drives OPC differentiation into mature, myelinating oligodendrocytes.

Myelin Sheath Formation: TYRO3 regulates expression of myelin basic protein (MBP) and other myelin components.

Node of Ranvier Organization: TYRO3 helps organize the nodes of Ranvier where action potentials are regenerated.

Clinical Implications

Diagnostic Applications

TYRO3 as a biomarker:

Cerebrospinal Fluid: Soluble TYRO3 in CSF may indicate neuronal injury or disease progression.

Blood-Brain Barrier: TYRO3 expression on cerebral endothelial cells may indicate BBB integrity.

Therapeutic Targeting

TYRO3 modulators in development:

Agonists: Small molecule TYRO3 agonists are in preclinical development for AD and PD.

Gene Therapy: AAV-mediated TYRO3 delivery to neurons is being explored.

Conclusion

TYRO3 represents a critical member of the TAM receptor family with unique roles in neuronal survival, synaptic function, and myelination. Its dysregulation in Alzheimer's disease, Parkinson's disease, and demyelinating disorders makes it an attractive therapeutic target.

See Also

• [TYRO3 Protein](/proteins/tyro3-protein) - Protein product page
• [TAM Receptor Signaling](/mechanisms/tam-receptor-signaling) - TAM family signaling pathway
• [Alzheimer's Disease](/diseases/alzheimers-disease) - Alzheimer's disease overview
• [Parkinson's Disease](/diseases/parkinsons-disease) - Parkinson's disease overview
• [Oligodendrocytes](/cell-types/oligodendrocytes) - Myelin-producing cells
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity) - Synaptic mechanisms

References

Pathway Diagram

The following diagram shows the key molecular relationships involving TYRO3 - TYRO3 Receptor Tyrosine Kinase discovered through SciDEX knowledge graph analysis: